Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / Common Stock
-
Number of holders
-
2
-
Total 13F shares, excl. options
-
749
-
Shares change
-
-395,514
-
Total reported value, excl. options
-
$2,000
-
Value change
-
-$889,987
-
Number of buys
-
2
-
Number of sells
-
-9
-
Price
-
$2.67
Significant Holders of MiNK Therapeutics, Inc. - Common Stock (INKT) as of Q2 2022
11 filings reported holding INKT - MiNK Therapeutics, Inc. - Common Stock as of Q2 2022.
MiNK Therapeutics, Inc. - Common Stock (INKT) has 2 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 749 shares
.
Largest 10 shareholders include MORGAN STANLEY (375 shares), FMR LLC (374 shares), AMERICAN INTERNATIONAL GROUP, INC. (0 shares), WELLS FARGO & COMPANY/MN (0 shares), STATE STREET CORP (0 shares), NEW YORK STATE COMMON RETIREMENT FUND (0 shares), RENAISSANCE TECHNOLOGIES LLC (0 shares), JPMORGAN CHASE & CO (0 shares), VANGUARD GROUP INC (0 shares), and BANK OF AMERICA CORP /DE/ (0 shares).
This table shows the top 2 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.